BS

Bharathi Sugali

Active Director Director DIN 08124746
DIN 08124746 First appointment May 2018 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Bharathi Sugali

Data last updated:

Bharathi Sugali is a Director at Sbe Pharma Private Limited (since 2018). The company operates in Business Services. Sbe Pharma Private Limited reported revenue of ₹63,003 (FY 2022).

DIN 08124746
Primary Designation Director
Industry Business Services
First Appointment 03 May 2018
Oldest Company Age 8 yrs
Largest company Sbe Pharma Private Limited · ₹63,003 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sbe Pharma Private Limited U74999TG2018PTC124225
Director03 May 20182018₹63,003 (FY 2022)Active

Board colleagues of Bharathi Sugali

NameDINCompanyDesignation
Sandeep Swamy08124745Sbe Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sbe Pharma Private Limited
Premium access

Shareholding and investment profile for Bharathi Sugali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bharathi Sugali

Bharathi Sugali currently holds 1 directorship: Sbe Pharma Private Limited (Director, since 03 May 2018, revenue ₹63,003 (FY 2022)).

Bharathi Sugali was first appointed on 03 May 2018 as Director at Sbe Pharma Private Limited.

The current boards of Bharathi Sugali's companies include Sandeep Swamy (Sbe Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available